{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:10:04Z","timestamp":1794809404222,"version":"4.9.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":700,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>The effects of interferon (IFN) treatment and the post-IFN treatment \u03b1-fetoprotein (AFP) levels on risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC) are unknown. To determine the relationship between AFP and alanine transaminase (ALT) levels and HCC risk, a cohort consisting of 1,818 patients histologically proven to have CHC treated with IFN were studied. Cumulative incidence and HCC risk were analyzed over a mean follow-up period of 6.1 years using the Kaplan-Meier method and Cox proportional hazard analysis. HCC developed in 179 study subjects. According to multivariate analysis, older age, male gender, advanced fibrosis, severe steatosis, lower serum albumin levels, non sustained virological response (non-SVR), and higher post-IFN treatment ALT or AFP levels were identified as independent factors significantly associated with HCC development. Cutoff values for ALT and AFP for prediction of future HCC were determined as 40 IU\/L and 6.0 ng\/mL, respectively, and negative predictive values of these cutoffs were high at 0.960 in each value. The cumulative incidence of HCC was significantly lower in patients whose post-IFN treatment ALT and AFP levels were suppressed to less than the cutoff values even in non-SVR patients. This suppressive effect was also found in patients whose post-IFN treatment ALT and AFP levels were reduced to less than the cutoff values despite abnormal pretreatment levels.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion\n                                 <\/jats:bold>\n                                 <jats:bold>: Post-IFN treatment ALT and AFP levels are significantly associated with hepatocarcinogenesis. Measurement of these values is useful for predicting future HCC risk after IFN treatment. Suppression of these values after IFN therapy reduces HCC risk even in patients without HCV eradication. (Hepatology 2013;58:1253\u20131262)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26442","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T10:08:49Z","timestamp":1365415729000},"page":"1253-1262","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":223,"title":["\u03b1-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C"],"prefix":"10.1097","volume":"58","author":[{"given":"Yasuhiro","family":"Asahina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuharu","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Itakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei","family":"Kakinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namiki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20241201","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1055\/s-2007-1007263","article-title":"Hepatitis C and hepatocellular carcinoma.","volume":"15","author":"Di Bisceglie","year":"1995","journal-title":"Semin Liver Dis"},{"key":"R2-11-20241201","doi-asserted-by":"crossref","first-page":"19071917","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma.","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"R3-11-20241201","doi-asserted-by":"crossref","first-page":"533543","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000.","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol"},{"key":"R4-11-20241201","doi-asserted-by":"crossref","first-page":"671675","DOI":"10.1002\/hep.1840120409","article-title":"Interrelationship of blood transfusion, nonA, nonB hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.","volume":"12","author":"Kiyosawa","year":"1990","journal-title":"Hepatology"},{"key":"R5-11-20241201","doi-asserted-by":"crossref","first-page":"518527","DOI":"10.1002\/hep.23691","article-title":"Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.","volume":"52","author":"Asahina","year":"2010","journal-title":"Hepatology"},{"key":"R6-11-20241201","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.7326\/0003-4819-129-2-199807150-00005","article-title":"Relation of IFN therapy and hepatocellular carcinoma in patients with chronic hepatitis C.","volume":"129","author":"Imai","year":"1998","journal-title":"Ann Intern Med"},{"key":"R7-11-20241201","doi-asserted-by":"crossref","first-page":"11241130","DOI":"10.1002\/hep.510290439","article-title":"Effect of IFN therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a longterm observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.","volume":"29","author":"Ikeda","year":"1999","journal-title":"Hepatology"},{"key":"R8-11-20241201","doi-asserted-by":"crossref","first-page":"174181","DOI":"10.7326\/0003-4819-131-3-199908030-00003","article-title":"IFN therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.","volume":"131","author":"Yoshida","year":"1999","journal-title":"Ann Intern Med"},{"key":"R9-11-20241201","doi-asserted-by":"crossref","first-page":"579587","DOI":"10.1002\/hep.21492","article-title":"SVR to IFNalpha is associated with improved outcome in HCVrelated cirrhosis: a retrospective study.","volume":"45","author":"Bruno","year":"2007","journal-title":"Hepatology"},{"key":"R10-11-20241201","first-page":"117133","article-title":"Molecular mechanisms of alphafetoprotein gene expression.","volume":"65","author":"Lazarevich","year":"2000","journal-title":"Biochemistry (Mosc)"},{"key":"R11-11-20241201","doi-asserted-by":"crossref","first-page":"157159","DOI":"10.1097\/00000441-199203000-00004","article-title":"Alphafetoprotein levels in normal adults.","volume":"303","author":"Ball","year":"1992","journal-title":"Am J Med Sci"},{"key":"R12-11-20241201","first-page":"149154","article-title":"Serum alphafetoprotein levels in healthy Japanese adults.","volume":"52","author":"Matsui","year":"1998","journal-title":"Acta Med Okayama"},{"key":"R13-11-20241201","doi-asserted-by":"crossref","first-page":"143154","DOI":"10.1055\/s-2005-871194","article-title":"Hepatocellular carcinoma: epidemiology, risk factors, and screening.","volume":"25","author":"Sherman","year":"2005","journal-title":"Semin Liver Dis"},{"key":"RU14-11-20241201","doi-asserted-by":"crossref","first-page":"570575","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum alphafetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and antiHCV status.","volume":"34","author":"Trevisani","year":"2001","journal-title":"J Hepatol"},{"key":"RU15-11-20241201","first-page":"16541658","article-title":"Utility of alphafetoprotein (AFP) in the screening of patients with virusrelated chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 Western patients.","volume":"47","author":"Cedrone","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"RU16-11-20241201","doi-asserted-by":"crossref","first-page":"S84S92","DOI":"10.1002\/hep.1840360711","article-title":"Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.","volume":"36","author":"Gebo","year":"2002","journal-title":"Hepatology"},{"key":"RU17-11-20241201","doi-asserted-by":"crossref","first-page":"679690","DOI":"10.1111\/j.1572-0241.2003.07327.x","article-title":"Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost utility analysis.","volume":"98","author":"Arguedas","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"RU18-11-20241201","doi-asserted-by":"crossref","first-page":"410417","DOI":"10.1053\/jhep.2002.34744","article-title":"Racial differences in effectiveness of alphafetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.","volume":"36","author":"Nguyen","year":"2002","journal-title":"Hepatology"},{"key":"R19-11-20241201","doi-asserted-by":"crossref","first-page":"21172120","DOI":"10.1002\/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7","article-title":"Elevations in serum alphafetoprotein levels in patients with chronic hepatitis B.","volume":"64","author":"Di Bisceglie","year":"1989","journal-title":"Cancer"},{"key":"R20-11-20241201","doi-asserted-by":"crossref","first-page":"133137","DOI":"10.1111\/j.1600-0676.1986.tb00279.x","article-title":"Alphafetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.","volume":"6","author":"Liaw","year":"1986","journal-title":"Liver"},{"key":"R21-11-20241201","doi-asserted-by":"crossref","first-page":"24522456","DOI":"10.1111\/j.1572-0241.1998.00703.x","article-title":"Serum alphafetoprotein levels and liver histology in patients with chronic hepatitis C.","volume":"93","author":"Bayati","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R22-11-20241201","doi-asserted-by":"crossref","first-page":"811816","DOI":"10.1093\/ajcp\/111.6.811","article-title":"Serum alphafetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB1 scores.","volume":"111","author":"Goldstein","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R23-11-20241201","doi-asserted-by":"crossref","first-page":"240244","DOI":"10.1097\/00004836-200103000-00014","article-title":"Clinical, virologic, and pathologic significance of elevated serum alphafetoprotein levels in patients with chronic hepatitis C.","volume":"32","author":"Chu","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"R24-11-20241201","doi-asserted-by":"crossref","first-page":"15131520","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging.","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"R25-11-20241201","doi-asserted-by":"crossref","first-page":"518526","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R26-11-20241201","first-page":"197203","article-title":"Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virusrelated cirrhosis: a longterm followup study.","volume":"19","author":"RodriguezDiaz","year":"2007","journal-title":"Clin Oncol"},{"key":"R27-11-20241201","doi-asserted-by":"crossref","first-page":"12081236","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma.","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"R28-11-20241201","doi-asserted-by":"crossref","first-page":"675680","DOI":"10.1056\/NEJM199109053251002","article-title":"Hepatocellular carcinoma in Italian patients with cirrhosis.","volume":"325","author":"Colombo","year":"1991","journal-title":"N Engl J Med"},{"key":"R29-11-20241201","doi-asserted-by":"crossref","first-page":"17971801","DOI":"10.1056\/NEJM199306243282501","article-title":"Risk factors for hepatocellular carcinoma among patients with chronic liver disease.","volume":"328","author":"Tsukuma","year":"1993","journal-title":"N Engl J Med"},{"key":"R30-11-20241201","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1002\/hep.1840190111","article-title":"Prospective study of alphafetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.","volume":"19","author":"Oka","year":"1994","journal-title":"Hepatology"},{"key":"R31-11-20241201","first-page":"11121118","article-title":"Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.","volume":"23","author":"GanneCarrie","year":"1996","journal-title":"Hepatology"},{"key":"R32-11-20241201","doi-asserted-by":"crossref","first-page":"15751580","DOI":"10.1111\/j.1572-0241.2001.03780.x","article-title":"Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.","volume":"96","author":"Sangiovanni","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R33-11-20241201","doi-asserted-by":"crossref","first-page":"10891097","DOI":"10.1016\/j.jhep.2006.02.008","article-title":"Prediction model of hepatocarcinogenesis for patients with hepatitis C virusrelated cirrhosis. Validation with internal and external cohorts.","volume":"44","author":"Ikeda","year":"2006","journal-title":"J Hepatol"},{"key":"R34-11-20241201","doi-asserted-by":"crossref","first-page":"179187","DOI":"10.1111\/j.1365-2893.2007.00928.x","article-title":"Clinical significance of elevated alphafetoprotein in Alaskan Native patients with chronic hepatitis C.","volume":"15","author":"Bruce","year":"2008","journal-title":"J Viral Hepat"},{"key":"R37-11-20241201","doi-asserted-by":"crossref","first-page":"444451","DOI":"10.1007\/s00535-011-0505-8","article-title":"Decrease in alphafetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.","volume":"47","author":"Osaki","year":"2012","journal-title":"J Gastroenterol"},{"key":"R38-11-20241201","doi-asserted-by":"crossref","first-page":"860865","DOI":"10.1111\/j.1572-0241.2004.04152.x","article-title":"Clinical significance of elevated alphafetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.","volume":"99","author":"Hu","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R39-11-20241201","doi-asserted-by":"crossref","first-page":"132137","DOI":"10.1016\/0006-2944(84)90015-2","article-title":"Serum alphafetoprotein in fulminant hepatitis and hepatic regeneration following partial hepatectomy.","volume":"32","author":"Watanabe","year":"1984","journal-title":"Biochem Med"},{"key":"R40-11-20241201","doi-asserted-by":"crossref","first-page":"626632","DOI":"10.1007\/s005350200099","article-title":"Decreasing serum alphafetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B.","volume":"37","author":"Yang","year":"2002","journal-title":"J Gastroenterol"},{"key":"R41-11-20241201","doi-asserted-by":"crossref","first-page":"351357","DOI":"10.1093\/ajcp\/112.3.351","article-title":"Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosis.","volume":"112","author":"Horn","year":"1999","journal-title":"Am J Clin Pathol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26442","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201310000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:08:28Z","timestamp":1733062108000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201310000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26442","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}